Get the Stockscreener App
0.00
100.00%
-0.0973
After Hours:
.10
0.10
+
Zomedica Corp Stock (ZOM) Latest News
Earnings call transcript: Zomedica Q4 2024 shows revenue growth - Investing.com India
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica (ZOM) Expected to Announce Quarterly Earnings on Thursday - Defense World
Zomedica Transitions to OTCQB Market Following NYSE Delisting - TipRanks
Zomedica Corp. Announces Transition to OTCQB Venture Market - ACCESS Newswire
About Us - Financial Content
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split - ACCESS Newswire
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - ACCESS Newswire
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Zomedica to Present at H.C. Wainwright Global Investment Conference - ACCESS Newswire
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses - ACCESS Newswire
Zomedica Provides Corporate Update - ACCESS Newswire
Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio - ACCESS Newswire
Zomedica to Present at JMP Securities Life Sciences Conference - ACCESS Newswire
Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors - ACCESS Newswire
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference - ACCESS Newswire
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET - ACCESS Newswire
When Will Zomedica Reveal Its 2024 Financial Performance? Key Date Announced - StockTitan
Zomedica stock hits 52-week low at $0.12 amid market challenges - Investing.com
Zomedica stock hits 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
Zomedica (NYSEAMERICAN:ZOM) Trading Down 0.7% – What’s Next? - Defense World
Observations on the Zomedica Corp (AMEX:ZOM) Growth Curve - US Post News
Zomedica Corp [ZOM] stock for 18,450 USD was acquired by Blair Anthony K - Knox Daily
ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan
Zomedica Relocates Headquarters, Cuts Costs by $200,000 Annually -February 12, 2025 at 09:15 am EST - Marketscreener.com
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - ACCESS Newswire
Smart Money Move: Zomedica's New HQ Cuts Expenses in Half, Accelerates Path to Profits - StockTitan
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners - ACCESS Newswire
Zomedica Corp [ZOM] Records 200-Day SMA of $0.1375 - Knox Daily
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - ACCESS Newswire
Experts predict Zomedica Corp’s (ZOM) current quarter earnings growth rate - US Post News
Zomedica Corp (ZOM) rating initates by Dawson James - Knox Daily
Zomedica (NYSEAMERICAN:ZOM) Shares Up 1.6%Here's Why - MarketBeat
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared - ACCESS Newswire
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - ACCESS Newswire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line - ACCESS Newswire
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors - ACCESS Newswire
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs - ACCESS Newswire
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System - ACCESS Newswire
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels - ACCESS Newswire
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - ACCESS Newswire
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - ACCESS Newswire
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America - ACCESS Newswire
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota - ACCESS Newswire
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - ACCESS Newswire
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - ACCESS Newswire
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) - ACCESS Newswire
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - ACCESS Newswire
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - ACCESS Newswire
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference - ACCESS Newswire
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - ACCESS Newswire
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - ACCESS Newswire
A Bull Market Continues To Unfold On Zomedica Corp (AMEX: ZOM), As It Continued To Rise 3.67% In Year-To-Date - Marketing Sentinel
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity - ACCESS Newswire
Zomedica Provides NYSE American Listing Update - ACCESS Newswire
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - ACCESS Newswire
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World
Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World
Zomedica (NYSEAMERICAN:ZOM) Shares Down 2.2%Should You Sell? - MarketBeat
0.77%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):